{"id":"NCT03840278","sponsor":"Massachusetts General Hospital","briefTitle":"The Bihormonal iLet Bionic Pancreas Feasibility Study","officialTitle":"The Bihormonal iLet Bionic Pancreas Feasibility Study","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2019-05-15","primaryCompletion":"2019-07-03","completion":"2019-07-03","firstPosted":"2019-02-15","resultsPosted":"2019-12-16","lastUpdate":"2019-12-16"},"enrollment":12,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 1 Diabetes Mellitus"],"interventions":[{"type":"DEVICE","name":"Bihormonal iLet Bionic Pancreas","otherNames":[]},{"type":"DEVICE","name":"Insulin-only Bionic Pancreas","otherNames":[]},{"type":"DRUG","name":"Dasiglucagon","otherNames":[]}],"arms":[{"label":"Bihormonal iLet first, then Insulin-Only iLet","type":"EXPERIMENTAL"},{"label":"Insulin-Only iLet first, then Bihormonal iLet","type":"EXPERIMENTAL"}],"summary":"Our objective is to evaluate the function of the bihormonal configuration of the ILet bionic pancreas delivering dasiglucagon when compared to the insulin-only configuration of the ILet bionic pancreas in a home-use study in adults with type 1 diabetes.","primaryOutcome":{"measure":"Percentage of Time That Valid CGM Glucose Readings Are Captured by the iLet Bionic Pancreas","timeFrame":"Days 1-7","effectByArm":[{"arm":"Bihormonal iLet Bionic Pancreas","deltaMin":89.2,"sd":6.4},{"arm":"Insulin-Only iLet Bionic Pancreas","deltaMin":91,"sd":6.4}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["33906916"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Nausea","Emesis"]}}